This site is intended for healthcare professionals only

England set to follow Scotland on pioneering HIV drug trial

Written by: | Published:

Will the trial bear fruit for at-risk patients? Will the trial bear fruit for at-risk patients?

Infection risks from HIV may be significantly reduced as trials for a pioneering preventative drug are announced for England.

NHS England announced that pre-exposure prophylaxis (PrEP) will now be provided in an initial three-year trial to around 10,000 people – making it the largest single study of its kind in the world.

READ MORE: 'Game-changing' HIV drug now available in Scotland

PrEP is already available for use in Scotland, following a legal battle led by campaigners from the Terrance Higgins Trust. Sexual health clinics in London, Brighton, Manchester, Liverpool and Sheffield will join the trial next month with others following shortly after. Full implementation is expected by April 2018 at the latest.

Terrence Higgins chief executive Ian Green Trust said: ‘We’re pleased that NHS England has announced a start date for the much anticipated PrEP trial. This trial has been gaining momentum in England, and is vital as we work towards ending HIV transmission.

‘The priority must now be to make sure that the trial is rolled out speedily across the country, and that no-one at risk of HIV is left behind. Now that the PrEP trial drug has been procured, we’re well on the way to protecting over 10,000 people at risk of HIV.’

READ MORE: HIV rates drop for first time

To support the study, NHS England has now concluded a successful international competitive procurement to source the PrEP drugs for this trial, priced at the programme’s allocated budget of £10 million, which also includes on-costs for local authorities and sexual health clinics involved in delivering and monitoring the trial intervention.

Clinics will identify eligible participants who consent to the trial, including men, women, transgender people, and individuals who have a partner whose HIV status is not known to be controlled by anti-retroviral treatment.

People living and registered with a GP in England will also be able to enrol for potential participation at their local participating sexual health clinic.

READ MORE: 'Complex' NHS system stalling progress on HIV treatment for ageing patients

In addition to investing in the PrEP trial, NHS England invests in a ‘treatment as prevention’ (TasP) policy to start HIV treatment earlier for people with diagnosed HIV to protect HIV-negative partners. This programme, combined with other prevention measures, has led to a more than 20% drop in new HIV diagnoses in large London clinics.

‘This major new intervention should complement and supercharge the wide-ranging and increasingly successful effort to prevent HIV,’ said NHS chief executive Simon Stevens. ‘It’s another milestone in more than three decade’s worth of progress in tackling one of humanity’s major health challenges.’

What do you think? Leave a comment below or tweet your views to @IndyNurseMag

This material is protected by MA Healthcare Ltd copyright.
See Terms and Conditions.

Comments

Name
 
Email
 
Comments
 

Please view our Terms and Conditions before leaving a comment.

Change the CAPTCHA codeSpeak the CAPTCHA code
 

Most read articles from Practice Nursing Journal

Practice Nursing Journal latest issue and most read articles.

Click here to read a selection of free to access articles from Practice Nursing Journal

Newsletter

Sign up to the newsletter

About

Independent Nurse is the professional resource for primary care and community nurses, providing clinical articles for practice nurses and prescribers.

Newsletter

Subscribe to our newsletter and stay up to date with the latest nursing news.

Stay Connected

Stay social with Independent Nurse by following us on Twitter, liking us on Facebook or connecting on LinkedIn.

Archive

Need access to some of our older articles? You can view our archive, or alternatively contact us.

Contact Us

MA Healthcare Ltd.
St Jude's Church, Dulwich Road
London, SE24 0PB

Tel: +44 (0)20 7738 5454
Registered in England and Wales No. 01878373

Meet the team

Authors

Find out how to contribute to Independent Nurse here.